Articles tagged with Substance Related Disorders
Researchers are exploring psychedelic-based treatments as a potential game-changer for patients with post-traumatic stress disorder (PTSD) and substance use disorders. Studies have shown improvements in symptoms of both conditions, offering new hope for those who have struggled with treatment-resistant disorders.
Researchers at Texas A&M University found that substance use impairs cognitive flexibility by inhibiting specific neurons. Chronic cocaine or alcohol use alters the local inhibitory brain circuit, leading to decreased cognitive flexibility and increased risk of academic deficits and lower quality of life.
Researchers found that individuals with AUD displayed less impairment on fine motor and cognitive tasks when consuming a standard dose of alcohol, but showed significant impairment at a higher dose. This suggests that the physical effects of alcohol accumulation contribute to impaired performance beyond mere tolerance.
The Better Together trial partners with community organizations and sites to provide buprenorphine treatment, reducing distance for patients and offering peer support in familiar environments. Researchers aim to address barriers such as stigma, misunderstandings about addiction, and bias against certain treatments.
A new study reveals that over 80% of people who inject drugs in New York City test positive for fentanyl, but only 18% intend to take it intentionally. The research suggests that widespread use of fentanyl among this population may be driving overdose risk and tolerance development.
A new study by Harvard T.H. Chan School of Public Health found significant racial inequalities in treatment for opioid use disorder, with White patients receiving medication up to 80% more frequently than Black and Hispanic patients. Despite similar numbers of healthcare visits, disparities persist.
A recent NIH study reveals that young men with cannabis use disorder are at a higher risk of developing schizophrenia. The study analyzed health records data from over 6 million people in Denmark and found that as many as 30% of schizophrenia cases among young men aged 21-30 might have been prevented by averting cannabis use disorder.
Researchers found that the 'Eat, Sleep, Console' (ESC) care approach is more effective than Finnegan Neonatal Abstinence Scoring Tool (FNAST) in assessing and managing opioid-exposed newborns. Newborns cared for with ESC were medically ready for discharge approximately 6.7 days earlier and 63% less likely to receive medication.
A new Twitter analysis reveals that medical dramas like New Amsterdam, Chicago Med, and Grey's Anatomy influenced hundreds of people's thoughts on vaping dangers. The study found that nearly half the tweets commented on the realism of the storylines, with some even expressing intention to quit vaping.
A new Northwestern Medicine study found that only 7% of Medicaid enrollees with opioid use disorder (OUD) received residential treatment, highlighting a significant gap in care. Residential treatment centers provide structured support and are considered one of the best treatments for severe substance use.
Research finds that endocannabinoids protect against addiction in individuals exposed to childhood maltreatment. The 'resilient' group showed increased function of the endocannabinoid system and different brain activity compared to other groups.
Researchers find that patients with destructive nasal lesions may be suffering from cocaine-induced granulomatosis with polyangiitis, a condition often misdiagnosed. Cocaine use can trigger production of antibodies leading to symptoms similar to idiopathic Granulomatosis With Polyangiitis.
A recent study found that heavy alcohol use changes signaling pathways in the brain, affecting cognitive functions like decision-making and impulse control. The mechanism involves the brain's immune system and the molecule interleukin 1β, which regulates inflammation and neurotransmitter release.
A recent study has found a significant link between fibromyalgia and increased odds of exacerbation in pain-related opioid use disorder. Researchers surveyed 125 individuals living with both conditions, revealing that those with fibromyalgia were more likely to report worsening addiction symptoms due to chronic pain.
A new study finds that smokeless tobacco products increase the risk of developing peripheral artery disease by two-fold compared to non-users. The study analyzed data from 14,344 participants and found a significant association between smokeless tobacco use and PAD, with a rate of 4.4 cases per 1,000 person years.
A new NIH study has identified common genetic markers underlying various substance use disorders, suggesting a link to dopamine signaling regulation. The findings may lead to more effective treatments and prevention strategies for multiple substance use disorders, including those with co-occurring mental health conditions.
A novel community-focused strategy implemented in Pennsylvania counties led to a 30% reduction in opioid overdose death rates. The approach, developed by University of Pittsburgh researchers, prevented 1,818 opioid-related deaths over two years.
A study found that long-acting injectable ART suppressed HIV in people with unstable housing, mental illnesses, and substance use disorders. The treatment improved outcomes in underserved patients, overcoming daily treatment barriers such as housing insecurity and untreated mental illnesses.
A study of 1,463 combat-deployed soldiers found significant associations between bullying/hazing and major depressive disorder, PTSD, suicidal thoughts, and substance use disorder. The findings highlight the need for efforts to prevent and address mental health problems among service members.
A study shows that pharmacies can offer a safe starting point for patients with opioid use disorder, leading to higher rates of retention in treatment. The pharmacy-based model increases access to buprenorphine, a lifesaving medication, for diverse patient populations and promotes racial and economic equity.
Researchers have discovered that vaping might not be a healthier alternative to smoking, especially in adolescents. EVALI symptoms can mimic those of other respiratory conditions, making diagnosis challenging. Pictorial questionnaires can help identify e-cigarette products used.
The NIH has established a research network to test community-based harm reduction strategies, including naloxone distribution and fentanyl test strips, to reduce overdose deaths. The network aims to save lives by connecting people who use drugs with services and treatments.
Researchers have created a chemical compound, Pillar[6]MaxQ (P6AS), which can counteract the effects of fentanyl and methamphetamine in lab experiments. The compound works as a molecular container, binding to drugs and reversing their biological properties.
US adults with mental health and substance use disorders saw significant reductions in smoking, while those without MH/SUD did not experience comparable changes. The study attributed these disparities to increased health insurance coverage under the ACA.
A 5-year follow-up study found patients who received a patient activation training had more primary care use and fewer substance-related emergency department visits. The intervention taught patients to connect with their primary care team, manage their health holistically, and overcome stigma associated with addiction treatment.
Researchers have isolated an effective monoclonal antibody that targets heroin, blocking its painkilling effect and overdose deaths in mice. The findings suggest that targeting heroin itself is more effective than its metabolites, paving the way for a new therapy.
Researchers at Indiana University have developed a virtual reality therapy to aid in substance use disorder recovery, using 'future-self avatars' to help people choose long-term rewards over immediate gratification. The technology has shown promising results in lowering relapse rates and increasing future self-connectedness.
Researchers at Queensland University of Technology have identified a precise neural circuit in the brain that controls long-term alcohol consumption in mice. Inhibiting the transmission of serotonin to a specific receptor has been shown to reduce alcohol consumption.
Researchers found that participants who remained in treatment programs less than 90 days had significantly higher initial cortisol levels, indicating a higher risk of early discontinuation. Lower cortisol levels were associated with longer treatment retention.
A study of rural communities in the US found that people using both methamphetamine and opioids had the highest risk of nonfatal overdose. The study suggests that addressing methamphetamine use alongside opioid use is crucial for reducing overdose rates in these communities.
A new study suggests targeting early adolescent impulsivity could prevent later behavioral disorders. The research found that adolescents with high levels of impulsivity in early adolescence were at risk for developing antisocial personality disorder and alcohol use disorder.
A Rutgers study found that participants with severe insomnia and high rates of alcohol use had lower blackout frequencies than those with low insulinemia, suggesting a potential link between circadian misalignment and altered alcohol metabolism.
A new study finds that large-scale HIV screening and peer support successfully reduced uncontrolled HIV in people who inject drugs by 40% in Haiphong, Vietnam. The intervention improved HIV identification and care among this at-risk population.
National data indicate that expanded access to methadone treatment during the COVID-19 pandemic did not lead to increased harms, but rather declined percentage of overdose deaths involving methadone. This evidence supports expanding take-home treatment for opioid use disorder.
A study published in PAIN Reports found that individuals with opioid use disorder (OUd) experience greater central sensitization, leading to worse quality of life. Central sensitization refers to abnormal pain processing in the brain and spinal cord, causing people to suffer more from pain.
Researchers assessed buprenorphine coverage and prior authorization requirements in US commercial formularies from 2017 to 2021. The study found that coverage and requirements changed over time, with more stringent regulations in place by 2021.
A pan-Canadian study found that prescribing buprenorphine-naloxone at home is as effective as traditional methadone treatment in reducing opioid use. The flexible model of care offers improved access and autonomy for individuals with opioid use disorder. With over 270 participants, the OPTIMA study suggests a new approach to treating t...
Researchers investigate how COVID-19 pandemic policies impacted access to life-saving treatment for opioid use disorder in minority groups. They aim to understand structural mechanisms of disparities and encourage the healthcare system to review and change social policies.
A new game called QuitBet is being tested to help people quit smoking by providing a fun and engaging way to adopt healthy habits. Players commit to quitting smoking over four weeks and bet $30, with winners typically doubling their money.
A study found significant reductions in cigarette use among U.S. adults with major depression, substance use disorder, or both from 2006 to 2019. Smoking cessation efforts remain critical for people with these conditions.
A significant decline in cigarette smoking prevalence was observed among US adults with major depressive episode or substance use disorder between 2006 and 2019. The study included nearly 560,000 participants and found a notable reduction in self-reported cigarette smoking during this period.
Researchers at Tokyo University of Science discovered that disulfiram inhibits FROUNT protein and chemokine signaling pathways, reducing anxiety levels in mice. The study suggests a potential breakthrough anti-anxiety medication with safe and effective treatment for elderly patients suffering from anxiety and insomnia.
A pair of studies published by Washington State University scientists found that hyperbaric oxygen therapy can help individuals with opioid addiction reduce their methadone dose and better manage pain and withdrawal symptoms. The treatment involves breathing pure oxygen in a pressurized environment, resulting in significant dose reduct...
A new study by Harvard Medical School researchers found that people who survive firearm injuries face greater risks of mental health disorders, substance use disorders, and pain in the year following injury. The analysis showed significant increases in healthcare spending, with gunshot survivors averaging $2,495 more per month compared...
Researchers found that female mice produce more of the FPR2 protein, which helps prevent NAFLD, and that estrogen mediates its production. This discovery highlights the need for sex-balanced animal experiments and could lead to novel treatments and gender-based therapies for NASH
Research reveals that smoking prevalence is significantly higher in underserved communities compared to the national average. Smoking is also associated with a higher risk of co-occurring mental health conditions and substance use disorders in these communities.
A new study published in JAMA Network Open finds that a combination treatment of nicotine replacement therapy and varenicline is more effective for smoking cessation in heavy drinkers, resulting in 44.3% abstinence rate. Participants also showed significant reductions in drinking rates, with 25% decrease in weekly drinking days.
Research from Tufts University scientists finds that opioid exposure in mothers can lead to metabolic disorders and type 2 diabetes in their sons. The study, published in Scientific Reports, suggests that even short-term use of opioids before pregnancy can have long-lasting effects on the health of future generations.
A new study finds that hospitals in predominantly Black and Hispanic areas have lower rates of offering programs addressing opioid use disorder. The researchers analyzed 446 nonprofit hospitals across the US, finding gaps in hospital-based services that contribute to racial disparities.
A team of scientists from Pusan National University conducted an updated meta-analysis to clarify the relationship between alcohol consumption and unprovoked seizures and epilepsy. They found that overall, alcohol drinkers were at a significantly higher risk of developing epilepsy compared to non-drinkers.
Researchers found that exposure to addiction medicine consult teams led to a significantly reduced risk of death within three months of discharge. Medication played a key role in reducing mortality for patients with opioid use disorders, while other components may be crucial for those with alcohol use disorder.
Researchers at MU developed a new framework to identify people previously overlooked for AUD, focusing on 13 risk factors such as impulsive behavior and reward sensitivity. The framework aims to provide more accurate diagnoses and connect individuals with tailored treatment options.
An analysis of data from 16 US states found that wine and spirit sales increased during the early months of the pandemic, while beer sales declined. Visits to liquor stores increased, but those to bars and pubs decreased.
A new study by NYU School of Global Public Health found racial disparities in opioid prescribing, with Blacks and Hispanics less likely to be prescribed opioids in the late 1990s. By the mid 2000s, prescription opioid use among Blacks matched that of whites, despite the focus on white populations during the opioid crisis.
A study of HIV-positive black and Latino men found that methamphetamine use combined with intimate partner violence boosts inflammatory and antiviral genes, leading to immune system exhaustion. This combination may increase the risk of developing cardiovascular disease and other disorders.
Pharmacy standing orders led to a significant increase in naloxone dispensing in Massachusetts, but gaps in access persist in rural communities and Hispanic neighborhoods. Communities with higher rates of opioid overdose deaths and buprenorphine treatment also dispensed more naloxone.
Researchers will investigate brain circuitry, neurochemicals and immune system interactions to understand why people living with HIV are more vulnerable to depression. They aim to identify specific biomarkers of depression and develop better treatments.
A recent study published in Behavioral Sleep Medicine found that people who wake up, smoke, and return to sleep are more likely driven by stress than nicotine addiction. To help these smokers quit, researchers recommend addressing their psychological distress and developing treatments that go beyond nicotine dependence.
A new study by Washington State University researchers found that relaxing limits on take-home methadone doses during the COVID-19 pandemic did not lead to worse treatment outcomes. The study saw a nearly doubling of methadone take-home doses but no significant changes in emergency department visits or methadone testing.
US car crash deaths involving cannabis have doubled between 2000 and 2018, with those also involving alcohol increasing by over 100%. Researchers found a significant link between cannabis use and increased risk of alcohol involvement in fatal crashes.